NCT06162468View on ClinicalTrials.gov

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions
Intraductal Papillary Mucinous Neoplasm of Pancreas
Interventions
PROCEDURE

Endoscopic ultrasound-guided pancreatic cyst chemoablation (EUS-PCA) using gemcitabine and paclitaxel

EUS-PCA using gemcitabine and paclitaxel

Trial Locations (2)

Unknown

Te Whatu Ora Waitematā, Auckland

Te Whatu Ora Waikato, Hamilton

All Listed Sponsors
collaborator

Gut Cancer Foundation, New Zealand

UNKNOWN

collaborator

North Shore Hospital, New Zealand

OTHER

collaborator

Waikato Hospital

OTHER

lead

University of Auckland, New Zealand

OTHER

NCT06162468 - Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts | Biotech Hunter | Biotech Hunter